Clinical epidemiology of COVID-19 among hospitalized children in rural western Kenya.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
02
2023
accepted:
12
05
2023
medline:
14
6
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
epublish
Résumé
The epidemiology of pediatric COVID-19 in sub-Saharan Africa and the role of fecal-oral transmission in SARS-CoV-2 are poorly understood. Among children and adolescents in Kenya, we identify correlates of COVID-19 infection, document the clinical outcomes of infection, and evaluate the prevalence and viability of SARS-CoV-2 in stool. We recruited a prospective cohort of hospitalized children aged two months to 15 years in western Kenya between March 1 and June 30 2021. Children with SARS-CoV-2 were followed monthly for 180-days after hospital discharge. Bivariable logistic regression analysis was used to identify the clinical and sociodemographics correlates of SARS-CoV-2 infection. We also calculated the prevalence of SARS-CoV-2 detection in stool of confirmed cases. Of 355 systematically tested children, 55 (15.5%) were positive and were included in the cohort. The commonest clinical features among COVID-19 cases were fever (42/55, 76%), cough (19/55, 35%), nausea and vomiting (19/55, 35%), and lethargy (19/55, 35%). There were no statistically significant difference in baseline sociodemographic and clinical characteristics between SARS-CoV-2 positive and negative participants. Among positive participants, 8/55 (14.5%, 95%CI: 5.3%-23.9%) died; seven during the inpatient period. Forty-nine children with COVID-19 had stool samples or rectal swabs available at baseline, 9 (17%) had PCR-positive stool or rectal swabs, but none had SARS-CoV-2 detected by culture. Syndromic identification of COVID-19 is particularly challenging among children as the presenting symptoms and signs mirror other common pediatric diseases. Mortality among children hospitalized with COVID-19 was high in this cohort but was comparable to mortality seen with other common illnesses in this setting. Among this small set of children with COVID-19 we detected SARS-CoV-2 DNA, but were not able to culture viable SARs-CoV-2 virus, in stool. This suggests that fecal transmission may not be a substantial risk in children recently diagnosed and hospitalized with COVID-19 infection.
Identifiants
pubmed: 37315023
doi: 10.1371/journal.pgph.0002011
pii: PGPH-D-23-00293
pmc: PMC10266603
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0002011Subventions
Organisme : Bill & Melinda Gates Foundation
ID : INV-016894
Pays : United States
Informations de copyright
Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
Gut. 2020 Aug;69(8):1543-1544
pubmed: 32312790
Endosc Int Open. 2021 Aug;9(8):E1276-E1282
pubmed: 34447876
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):269-283
pubmed: 33589829
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2
pubmed: 32534042
Front Pediatr. 2020 Nov 02;8:591132
pubmed: 33224909
Ann Med Surg (Lond). 2021 Apr;64:102204
pubmed: 33692899
Osong Public Health Res Perspect. 2020 Jun;11(3):112-117
pubmed: 32528816
Jpn J Infect Dis. 2022 Jan 24;75(1):36-40
pubmed: 34053956
Pediatr Infect Dis J. 2021 Apr 1;40(4):e137-e145
pubmed: 33538539
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
PLoS One. 2021 Sep 7;16(9):e0257045
pubmed: 34492085
Paediatr Respir Rev. 2020 Sep;35:70-74
pubmed: 32654854
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1753-1759.e2
pubmed: 32311512
Acta Paediatr. 2007 Oct;96(10):1526-30
pubmed: 17850399
Lancet Child Adolesc Health. 2021 Aug;5(8):559-568
pubmed: 34119027
Gastroenterol Hepatol. 2022 Oct;45(8):593-604
pubmed: 35077722
Lancet Infect Dis. 2021 May;21(5):617-628
pubmed: 33476567
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088
pubmed: 32790664
CMAJ. 2021 Jan 4;193(1):E1-E9
pubmed: 33234533
Paediatr Respir Rev. 2021 Jun;38:51-57
pubmed: 32891582
J Med Virol. 2021 Feb;93(2):719-725
pubmed: 32706393
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665
pubmed: 32633856
JAMA Pediatr. 2022 Mar 01;176(3):e216436
pubmed: 35044430
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Epidemiol Infect. 2021 Jul 02;149:e193
pubmed: 34210371
Am J Infect Control. 2021 Jan;49(1):21-29
pubmed: 32659413
China CDC Wkly. 2020 Feb 21;2(8):123-124
pubmed: 34594837
Am J Otolaryngol. 2020 Sep - Oct;41(5):102573
pubmed: 32531620
Aliment Pharmacol Ther. 2020 May;51(9):843-851
pubmed: 32222988
Clin Infect Dis. 2021 Jun 15;72(12):e938-e944
pubmed: 33170927
Arch Dis Child. 2020 Dec 17;:
pubmed: 33334728
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Pan Afr Med J. 2022 Jan 07;41:16
pubmed: 35291361
Arch Dis Child. 2021 Feb 16;:
pubmed: 33593743
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004